Kobe Steel’s data scandal shows cost of race to improve metalsKobe Steel rocked Japan’s industrial economy with revelations this week that it faked data on the quality of some aluminum, copper and iron...
Jindal Poly Films in talks to acquire European operations of DuPont Teijin FilmsIf completed, the acquisition will propel the company to the world's largest in a category that's dominated by Chinese conglomerate Kangde ...
Kumar Mangalam Birla's secret idea could take the world of business by stormThe Birla Group, the $40-billion mining-to-mobile phone carrier conglomerate, may buy this wonder manufacturing technology, sources reveale...
- Textile companies gung ho on Indo-Japan FTA
As India and Japan get closer to signing a free trade pact, textile and clothing majors from both the countries are exploring opportunities...
- Indian, Japanese firms must stitch textile alliances: Maran
Union minister for textiles Dayanidhi Maran has invited Japanese textiles industry to collaborate with their Indian counterparts in manufac...
'There will be consolidation in generics'We are looking at acquisitions in the US market to make an inroad. We are also concentrating on developing the BRIC countries and building ...
- Glenmark's Swiss arm gets $15 mn milestone payment from Forest Labs
Glenmark Pharmaceuticals SA, the Swiss subsidiary of Glenmark Pharmaceuticals, has received a milestone payment of $15 million from Forest ...
- Glenmark gets domestic patent for NCE
In what is perhaps the first domestic patent for a new chemical entity (NCE) by an Indian company, drug research company Glenmark Pharmaceu...
- Glenmark soars on likely deal of $150 mn
Market participants expect payout to Glenmark from such a deal would include upfront and milestone payments and royalties on sales.
- Glenmark to enter Europe with Rs 100 crore buy
Leading mid-sized pharma company Glenmark Pharmaceuticals would soon enter the European market by acquiring a front-end pharmaceutical comp...
- Drug research was way forward: Glenmark
After much analysis, consultants advised Glenmark Pharmaceuticals to stay away from research as it lacked the resources needed for innovati...
- Foreign players look at India to develop lower-cost drugs
German pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
- Glenmark to make Europe foray with Rs 100 cr buy
Leading mid-sized pharma company Glenmark Pharmaceuticals will soon enter the European market by acquiring a front-end pharmaceutical compa...
- Wanted, MNC allies
New drug discoveries are the pharmaceutical equivalent of an alchemist’s search for a magic formula to turn base metals into gold.